Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Income from Continuing Operations (2020 - 2025)

Historic Income from Continuing Operations for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to -$9.8 million.

  • RxSight's Income from Continuing Operations fell 5487.54% to -$9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$35.7 million, marking a year-over-year decrease of 1640.28%. This contributed to the annual value of -$27.5 million for FY2024, which is 4351.78% up from last year.
  • According to the latest figures from Q3 2025, RxSight's Income from Continuing Operations is -$9.8 million, which was down 5487.54% from -$11.8 million recorded in Q2 2025.
  • RxSight's 5-year Income from Continuing Operations high stood at -$5.9 million for Q4 2024, and its period low was -$17.6 million during Q1 2022.
  • In the last 5 years, RxSight's Income from Continuing Operations had a median value of -$12.4 million in 2023 and averaged -$11.6 million.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first crashed by 15988.97% in 2021, then soared by 5596.2% in 2024.
  • Quarter analysis of 5 years shows RxSight's Income from Continuing Operations stood at -$15.7 million in 2021, then grew by 0.86% to -$15.6 million in 2022, then skyrocketed by 41.21% to -$9.2 million in 2023, then surged by 35.3% to -$5.9 million in 2024, then tumbled by 65.28% to -$9.8 million in 2025.
  • Its Income from Continuing Operations stands at -$9.8 million for Q3 2025, versus -$11.8 million for Q2 2025 and -$8.2 million for Q1 2025.